George B. Abercrombie's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 49,933 Automatic Stock Option Grant done . Disclosure was reported to the exchange on June 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 12 Jun 2024 | 49,933 | 49,933 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 12 Jun 2024 | 6,820 | 36,431 (0%) | 0% | 0 | Common Stock | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 13 Jun 2023 | 39,072 | 39,072 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 13 Jun 2023 | 16,745 | 29,611 (0%) | 0% | 0 | Common Stock | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 07 Jun 2022 | 30,022 | 30,022 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 07 Jun 2022 | 12,866 | 12,866 (0%) | 0% | 0 | Common Stock | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 18 Apr 2022 | 5,000 | 5,000 (0%) | 0% | 3.3 | 16,600 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 18 Apr 2022 | 5,000 | 0 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 18 Apr 2022 | 5,000 | 0 (0%) | 0% | 11.0 | 55,200 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Feb 2022 | 5,000 | 0 (0%) | 0% | 18.5 | 92,500 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Feb 2022 | 5,000 | 5,000 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Feb 2022 | 5,000 | 5,000 (0%) | 0% | 3.3 | 16,600 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Nov 2021 | 5,000 | 5,000 (0%) | 0% | 3.3 | 16,600 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Nov 2021 | 5,000 | 10,000 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Nov 2021 | 5,000 | 0 (0%) | 0% | 12.3 | 61,350 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Sep 2021 | 5,000 | 0 (0%) | 0% | 15.1 | 75,300 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Sep 2021 | 5,000 | 0 | - | - | Non-Qualified Stock Option | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Sep 2021 | 5,000 | 5,000 (0%) | 0% | 2.6 | 13,150 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 Sep 2021 | 74,000 | 0 (0%) | 0% | 15.1 | 1,116,660 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 Sep 2021 | 30,000 | 44,000 (0%) | 0% | 3.2 | 96,600 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 Sep 2021 | 30,000 | 0 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 Sep 2021 | 30,000 | 0 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 Sep 2021 | 30,000 | 74,000 (0%) | 0% | 2.9 | 87,300 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 Sep 2021 | 11,000 | 0 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 Sep 2021 | 11,000 | 14,000 (0%) | 0% | 1.7 | 18,810 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Jul 2021 | 5,000 | 8,000 (0%) | 0% | 2.6 | 13,150 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Jul 2021 | 5,000 | 5,000 | - | - | Non-Qualified Stock Option | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 15 Jul 2021 | 5,000 | 3,000 (0%) | 0% | 15.7 | 78,450 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 25 May 2021 | 40,000 | 40,000 | - | - | Automatic Stock Option Grant | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 24 May 2021 | 6,667 | 10,000 | - | - | Non-Qualified Stock Option | ||
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 24 May 2021 | 6,667 | 3,000 (0%) | 0% | 13.9 | 92,671 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 24 May 2021 | 6,667 | 9,667 (0%) | 0% | 2.6 | 17,534 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | George B. Abercrombie | Director | 10 May 2021 | 7,000 | 3,000 (0%) | 0% | 12.7 | 88,900 | Common Stock |